PlateletDiagnostics, LLC (PlateletDx.com) today announced the development of a first-in-class platelet function assay that measures phosphorylation of the abundant platelet protein, dynamin-related ...
Results from a phase 2 clinical trial designed and overseen by researchers at Mass General Brigham Cancer Institute show that ...
Boehringer Ingelheim and the Lower Franconian biotech company EMFRET Analytics have signed a cooperation and license agreement for the preclinical development program of the GPVI‑blocking antibody ...
BACKGROUND: Despite antiplatelet therapy, some patients remain at high ischemic risk because of drug nonresponsiveness or high residual platelet reactivity). We aimed to target an orphan platelet GPCR ...
MedPage Today on MSN
Anti-CD38 antibody safe, effective in immune thrombocytopenia
Small trial shows similar rate of adverse events to placebo ...
Scientists have identified a handful of microRNAs (miRNAs) that appear to play a significant role in the development of platelets – blood cells critical to the body's ability to form clots following ...
PlateletDiagnostics develops novel immune-based platelet function assay to monitor antiplatelet therapy: Watertown, Massachusetts Wednesday, April 8, 2026, 18:00 Hrs [IST] Platele ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results